Ephicacy Consulting Group, Inc. ("Ephicacy" or “the Company”), a leading biometrics Contract Research Organization ("CRO"), today announced the appointment of Tara Gladwell as Chief Executive Officer. Founder Ganesh Gopal will transition to the role of Chairman and President to support the Company’s strategic growth plans.
Ms. Gladwell brings nearly three decades of industry expertise with more than a decade in leadership positions. She joins Ephicacy from Rho, a global CRO, where she served as President and led the Company’s growth strategy.
“My nearly-thirty-year career has been in the healthcare CRO industry, and I’m thrilled to bring my expertise to a leading provider in the space,” Ms. Gladwell said. “Innovating client care is at the heart of what Ephicacy does – we have that in common, and together I’m confident we’ll achieve new heights for the Company.”
Since founding in 2005, Ephicacy has grown into a leading biometrics CRO leveraging its global talent pool to deliver clinical analytics services. Ephicacy’s flexible service delivery approach offering Functional Service Provider (“FSP”) and project-based solutions to its client base allows global pharmaceutical and biotechnology companies to bring innovative new drugs to market in a safe, effective manner.
“Tara’s significant leadership experience, strong growth mindset, and impressive track record aligns perfectly with our business goals,” Ephicacy Founder Ganesh Gopal said. “Our company is well positioned in the market and poised to achieve growth objectives in the next few years with Tara at the helm. I look forward to being a partner in this next phase of growth as Chairman and President where I’ll be able to leverage my industry expertise to open new doors for the business.”
In 2022, Great Point Partners (“GPP”), a Greenwich-based private investment firm focused exclusively on the health care industry, invested in Ephicacy. GPP has invested in 15 outsourced pharmaceutical services businesses and has helped them successfully scale globally.
About Ephicacy Consulting Group, Inc.
Headquartered in Iselin, NJ, with employees and operations across North America and India, Ephicacy is a rapidly growing biometrics CRO, providing outsourced statistical programming, biostatistics, data management, and real-world evidence analytics services to pharmaceutical and biotechnology companies. Since its founding in 2005, Ephicacy has established itself as a leading player in the clinical analytics space, leveraging a global talent pool to help global pharmaceutical and biotechnology companies reduce their time to market in a cost-effective manner. More information on the Company and its services can be viewed online at www.ephicacy.com.
About Great Point Partners
Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with 30 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new minority and majority private equity investments from GPP IV. Great Point manages approximately $1.5B of capital (including committed and uncalled capital) in its private funds and public life sciences equity strategy (BioMedical Value Fund). Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with a particular emphasis on biopharmaceutical services and supplies, alternate site care, medical device contract manufacturing and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250225851423/en/
Contacts
DeLaney Cittadino
Prosek Partners
dcittadino@prosek.com
